STAT August 15, 2024
Joseph Howlett, Andrea Tamayo

Switching to IV treatments cuts out-of-pocket expenses but carries risks

As many as 40,000 chronically ill seniors are choosing to endure uncomfortable, time-consuming intravenous infusions because Medicare doesn’t sufficiently cover far more convenient, and less distressing, at-home treatments with the arthritis drug Humira.

When rheumatoid arthritis patients enroll in...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Medicare, Patient / Consumer, Provider
More than half of US adults could benefit from GLP-1 medications, researchers find
Data show 24.3% of U.S. adults had chronic pain in past three months in 2023
GLP-1 drug coverage for obesity making inroads with large employers: Mercer
Wearable Health Tech: Innovations and Impacts on Chronic Disease Management
Advocate Health takes to Capitol Hill on hospital at home: 5 notes

Share This Article